RRP S4E innovation Unlisted Shares Price
₹148▼37.02%(87.00)
About the company
RRP S4E Innovation Pvt. Ltd. is an Indian technology company focused on developing advanced defence and engineering solutions. With strong expertise in electro-optic systems, the company specializes in the repair, refurbishment, upgrade, and manufacturing of mission-critical equipment used by the Indian Armed Forces. By combining innovation with precision engineering, RRP S4E Innovation has established itself as a trusted technology partner in the defence sector.
The company has built its capabilities around cutting-edge technologies such as nano-spectrometry, vacuum systems, and elemental analysis, allowing it to deliver high-performance solutions while maintaining cost efficiency. Its emphasis on in-house research, product development, and engineering excellence enables the company to offer reliable solutions that meet stringent defence and industrial standards.
Fundamentals
Valuation
| Metric | Value |
|---|---|
| 52 week high | ₹365 |
| 52 week low | ₹144 |
| P/B ratio | 0.97 |
| Debt to equity | 0.1 |
| ROE (%) | 11.88% |
| Book value | ₹157.09 |
| Face value | ₹10 |
52 week high
52 week low
P/B ratio
Debt
Equity
ROE (%)
| Metric | Value |
|---|---|
| 52 week high | ₹365 |
| 52 week low | ₹144 |
| P/B ratio | 0.97 |
| Debt | 9.1% of capital |
| Equity | 90.9% of capital |
| ROE (%) | 11.88% |
Registry
| Metric | Value |
|---|---|
| PAN number | AAICR7373J |
| ISIN number | INE09FT01019 |
Figures in lk ·
Financials
| P&L Statement | 2024Latest | 2023 | 2022 |
|---|---|---|---|
| Revenue | 4057 | 3120 | 3831 |
| EBITDA | 2063 | 1589 | 1227 |
| OPM | 50.85 | 50.93 | 32.03 |
| PBT | 1627 | 1131 | 862 |
| PAT | 1285 | 853 | 622 |
| EPS | 15.08 | 11.89 | 13.07 |
Shareholding Pattern
Rajendra Kamalakant Chodankar
Priyanka Rajendra Chodankar
Maharashtra Defence & ASF
Mantaraj Paliwal
OTHERS
| Holder | Percentage |
|---|---|
| Rajendra Kamalakant Chodankar | 23.47% |
| Priyanka Rajendra Chodankar | 19.00% |
| Maharashtra Defence & ASF | 9.76% |
| Mantaraj Paliwal | 4.47% |
| OTHERS | 43.30% |
Leadership
| Name | Role | Experience | |
|---|---|---|---|
| Rajendra Kamalakant Chodankar | Founder & Chariman | 30+ yrs experience |
Unlisted Trending shares
High-demand unlisted opportunities currently available for trade.
MARKET INSIGHTS & UPDATES
Read the latest updates, investment ideas, and market insights designed to help investors better understand unlisted and pre-IPO opportunities.

NSE IPO 2026: Dates, Allotment & Listing Details
The much-awaited NSE IPO is set to make a major market debut in September 2026. As per the announced schedule, the IPO will open on 21 September and close on 23 September 2026, followed by share allotment on 24 September and listing on 28 September 2026. With strong investor interest and NSE’s position as one of India’s leading market institutions, the IPO is expected to attract significant attention. Here’s a quick look at the NSE IPO 2026 timeline and important dates investors should know.

Upcoming IPOs in 2026: NSE, Rentomojo, Manipal & Pranav Guide
Four major 2026 IPOs: NSE, Manipal Payment, Rentomojo, Pranav Constructions. For pre-IPO investors, these mark critical transitions from private to public valuations. Conduct due diligence before investing.

Purple Style Labs: From Unlisted Shares to IPO - A Price Journey Worth Noticing
Purple Style Labs is making headlines as it moves from the unlisted market towards its IPO. With its unlisted shares trading around ₹500–₹525 and an IPO price band of ₹546–₹575, the price journey offers an interesting look at how private-market and IPO valuations can differ.

Muthoot FinCorp Unlisted Shares: Q1FY27 Profit Surges to ₹705 Cr | Fundamentals & IPO
Muthoot FinCorp's Q1FY27 profit surged to ₹705.48 crore as the company moves toward a proposed ₹3,000-crore IPO. Here's a look at its financial performance, valuation metrics, asset quality and key fundamentals.

From Debt to Debt-Free: How API Holdings Used Thyrocare to Reshape Its Balance Sheet
API Holdings has repaid ₹1,050 crore of debt by monetising a 9.90% stake in Thyrocare while retaining 51.02% control. Here's how the move reshapes its balance sheet and what it means going forward.

Pre IPO Shares in India: Price, How to Buy & Complete Guide
Learn what Pre IPO Shares are, how their prices are determined, how to buy them in India, and what investors should check before investing in unlisted companies.
